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A B S T R A C T
Background: Cigarette smoking is a risk factor for ageing-related disease, but its association with biological
ageing, indicated by telomere length, is unclear.
Methods: We systematically reviewed evidence evaluating association between smoking status and telomere
length. Searches were performed in MEDLINE (Ovid) and EMBASE (Ovid) databases, combining variation of
keywords “smoking” and “telomere”. Data was extracted for study characteristics and estimates for association
between smoking and telomere length. Quality of studies was assessed with a risk of bias score, and publication
bias was assessed with a funnel plot. I2 test was used to observe heterogeneity. Meta-analysis was carried out to
compare mean diﬀerence in telomere length by smoking status, and a dose-response approach was carried out
for pack-years of smoking and telomere length. A sensitivity analysis was carried out to examine sources of
heterogeneity.
Results: A total of 84 studies were included in the review, and 30 among them were included in our meta-
analysis. Potential bias was addressed in half of included studies, and there was little evidence of small study
bias. Telomere length was shorter among ever smokers compared to never smokers (summary standard mean
diﬀerence [SMD]: −0.11 (95% CI −0.16 to −0.07)). Similarly, shorter telomere length was found among
smokers compared to non-smokers, and among current smokers compared to never or former smokers. Dose-
response meta-analysis suggested an inverse trend between pack-years of smoking and telomere length.
However, heterogeneity among some analyses was observed.
Conclusion: Shorter telomeres among ever smokers compared to those who never smoked may imply mechan-
isms linking tobacco smoke exposure to ageing-related disease.
1. Introduction
Telomeres are ribonucleoprotein structures at the end of linear
chromosomes essential for maintaining genome stability (Blackburn,
2001; Cech, 2008; O’Sullivan and Karlseder, 2010). Consisting of
tandem arrays of TTAGGG sequence, telomeres serve as dispensable
DNA sequences that shield genomic DNA from inevitable shortening
during replication (Lingner et al., 1995). In addition, the special cap
structure at the end of telomeric repeats, formed by 3’ G-strand over-
hang and telomere associated binding proteins, prevent recognition of
the linear chromosome ends as DNA double strand break by the DNA
repair machinery that may result in chromosome fusions (Griﬃth et al.,
1999; Longhese, 2008; Van Steensel et al., 1998; Verdun and Karlseder,
2007).
Human telomeres shorten with each cell division and as telomeres
become critically short, cells will cease proliferating and become se-
nescent. As such, telomere length has long been considered as a marker
of cellular aging (Bernadotte et al., 2016; Fyhrquist et al., 2011;
Kuilman et al., 2010). In addition to genetic factor (Broer et al., 2013),
environmental inﬂuences play an important role in determining telo-
mere length (Huda et al., 2007; Starkweather et al., 2014). Tobacco
smoking is a well-known health risk factor and exposure to harmful
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chemicals in cigarettes may induce oxidative stress and irreparable
damage to the telomeric DNA (Alexandrov et al., 2006, 2016; Asami
et al., 1996; d’Adda di Fagagna et al., 2003; Opresko et al., 2005; Von
Zglinicki, 2002). Despite this biological link, there have been incon-
sistencies in the literature regarding association between telomere
length and smoking, with some studies showing shorter telomeres with
smoking (Mirabello et al., 2009; Revesz et al., 2015) whereas a lack of
association was reported in other studies (Brouilette et al., 2003; Harris
et al., 2012). We therefore performed this systematic review and meta-
analysis to determine whether combined evidence supports association
between telomere length and smoking.
2. Methods
2.1. Search strategy
The meta-analysis was conducted according to the MOOSE (Stroup
et al., 2000) And PRISMA guidelines (Moher et al., 2009). MEDLINE
(Ovid) and EMBASE (Ovid) databases were searched from their incep-
tion to 29 April 2016, with the ﬁnal search performed on 02/05/2016.
We applied a search strategy as follows: (smoking OR cigarette*) AND
(telomere OR telomeres) as free text. Searches were limited to studies
conducted in humans. No language restriction was applied. References
from eligible studies were hand-searched for additional studies. Two
investigators independently identiﬁed eligible studies, and any dis-
crepancies were resolved by consensus with a third investigator. There
was no prior review protocol published for this study.
2.2. Inclusion criteria
We included studies that investigated an association between ci-
garette smoking status (including smoking status e.g. smokers, former
smokers and never smokers and smoking intensity) and telomere length
in humans, in which smoking status and telomere length were mea-
sured in the same subjects. Studies were either cross-sectional, cohort,
or case-control studies in humans. We included studies in which
smoking or telomere length was used as an adjustment variable if in-
dividual estimates of association between smoking and telomere length
were available.
2.3. Exclusion criteria
Duplicated publications or additional studies of already included
studies were excluded. We also excluded studies which did not fulﬁl any
inclusion criteria, for instance, those which did not provide estimates
for association between smoking and telomere length.
2.4. Data extraction
Data from eligible studies were independently extracted using a
standard form. The following information was collected: ﬁrst author,
year of publication, type of study, description of study population (age,
sex, race, country of study), method of telomere length measurement,
source of sample used, description of smoking exposure assessment,
sample size, comparison method, main results including maximally
adjusted eﬀect size and standard error or conﬁdence intervals, any
adjustment variables, and any other relevant information.
When information was available in the included studies, estimates
for the following comparisons were collected: 1) current smokers and
non-smokers, the latter of which consisted of former and never smokers,
2) ever smokers, which included both current and former smokers, and
never smokers, 3) current smokers and former smokers, 3) current
smokers and never smokers, 4) former smokers and never smokers, 5)
smoking intensity, expressed as pack-years of cigarette, deﬁned a pro-
duct of packs of cigarettes smoked per day and smoking duration in
years (Müezzinler et al., 2015), 6) levels of cotinine, a metabolite of
nicotine (Block et al., 2006). When multiple measurements were
available, we collected smoking status and telomere length measured at
the same time, or closest to each other.
For studies which only reported estimates for categories e.g. quar-
tiles of pack-year of cigarettes, we assigned interval scores of categories
from the original studies based on medians or means when available.
Category midranges were applied for the remaining closed-ended ca-
tegories. For upper open-ended categories with bi as the lower bound of
the ith interval and the intervals indexed by i = 1,…,n, interval scores
were assigned as bn + 0.5 (bn - bn-1) (Greenland and Longnecker, 1992;
Il’yasova et al., 2005). Correspondingly, interval scores for the lower
open-ended categories were assigned as b2 − 0.5 (b2 - b1).
2.5. Assessment of quality of included studies
Although quantitative scores have been used for meta-analysis of
observational studies (Mundstock et al., 2015), interpretation could be
challenging. We adapted assessment criteria from items in Critical
Appraisal Skills Programme (CASP) questionnaires (Critical Appraisal
Skills Programme, 2017) to assess cohort and case-control studies and
use these criteria to assess included studies: (i) Did the study address a
clearly focused issue? (ii) Did the authors use an appropriate method to
answer their question? (iii) Was the exposure accurately measured to
minimise bias? (iv) Was the outcome accurately measured to minimise
bias? (v) Have they taken account of important confounding factors in
the design and/or analysis? (vi) Do the results ﬁt with other available
evidence? Each item was answered with ‘Yes’, ‘No’ or ‘Don’t know’,
according to information presented in the publications.
2.6. Assessment of publication bias
Assessment for publication bias was carried out by assessing funnel
plot asymmetry for comparisons including at least 10 studies (Sterne
et al., 2011). Data points were derived from estimates and standard
errors from individual studies in relation to the pooled estimate eﬀect.
Asymmetrical distribution of data points for smaller studies (those with
wider standard errors) indicates small study eﬀects, which may be
caused by publication bias. In addition to visual inspection of the funnel
plot, we also conducted Egger's test, which applies weighted linear
regression analysis to test for funnel plot asymmetry. A p-value of< 0.1
was considered to represent signiﬁcant asymmetry (Egger et al., 1997).
Where asymmetry was indicated, sensitivity analysis was performed to
seek potential sources of asymmetry.
2.7. Assessment of heterogeneity
The studies were evaluated clinically and methodologically to assess
if it was reasonable to consider combining data. Statistical hetero-
geneity was measured by the visual inspection of the forest plots and
statistically through an assessment of homogeneity based on the Chi2
test (Higgins and Greenland, 2011). The I2 measurement was calculated
as an indicator of the amount of statistical variation not attributable to
sampling error. A value of more than 75% was considered to represent
high heterogeneity (Higgins et al., 2003).
2.8. Meta-analysis
A random eﬀects meta-analysis was performed to obtain pooled
results for each aforementioned comparison. Because diﬀerent methods
were used to assess telomere length, a standardised mean diﬀerence
(SMD) approach was applied in the analysis. Summary results were
obtained from ﬁnal values and their variance in individual studies. A
sensitivity analysis was performed by excluding studies one at a time.
Where diﬀerence in means were presented for categories of exposure,
e.g. for pack-year of smoking, we performed a two-stage meta-analysis
approach (Crippa and Orsini, 2016). First, a dose-response model was
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estimated within each study taking into account the covariance of SMD
corresponding to each assigned interval score. In the second stage,
study-speciﬁc estimates were combined using a multivariate random
eﬀects model. Linear and quadratic dose-response associations were
assessed, and Aikake information criterion (AIC) values were used to
compare model ﬁt. Where necessary, we performed a sensitivity ana-
lysis excluding one study at a time to determine potential sources of any
observed heterogeneity. Analyses were performed using the package
metafor and dosresmeta in R version 3.3.2 (R Foundation for Statistical
Computing, Vienna, Austria Foundation for R Foundation for Statistical
Computing, Vienna, Austriatatistical Computing, Vienna, Austria) and
OpenMetaAnalyst software (Wallace et al., 2012).
3. Results
As shown in Fig. 1, we identiﬁed a total of 616 studies from initial
search, of which 373 study duplicates were removed. After title and
abstract screening, full-text articles for 190 studies were retrieved.
Among these articles, we further excluded 110 studies for reasons re-
ported in Fig. 1 and full-text articles for the remaining 80 studies were
retrieved for detailed reviewing. Finally, 4 additional studies identiﬁed
among references in retrieved studies were included, resulting in a total
of 84 articles selected for systematic review. Of these, 30 reported
suﬃcient data for inclusion in meta-analysis.
3.1. Systematic review
Main characteristics of the included studies are summarised in
Table 1, and references containing included studies are included in the
Supplementary Information. Forty three studies were conducted in
Europe, 25 in North America, 12 in Asia, 2 in Africa, and 2 in South
America. In total, these studies involved 144,504 adults (age 18 and
older) and most studies include both men and women (Table S1,
Supplementary Information). Although some studies were longitudinal,
all collected smoking status and telomere length were assessed cross-
sectionally. Most studies used a single assessment of telomere length.
Smoking status was self-reported in these studies. Measurements of
telomere length were performed in the majority (75%) of the included
studies and peripheral blood or leukocytes were mostly used as tissue
source of DNA. Overall, among the 84 studies included, thirty-three
reported shorter telomere length with smoking, one study reported
longer telomere length with smoking, and ﬁfty found a lack of asso-
ciation between smoking and telomere length. Only one included study
(Verde et al., 2015) and a secondary analysis of study already included
in the review (Patel et al., 2016) assessed the association between co-
tinine levels, in which shorter telomeres were indicated with higher
cotinine levels. A meta-analysis was not possible because mean diﬀer-
ence in telomere length was only available in one study. Time since
quitting smoking was assessed in two studies (Müezzinler et al., 2015;
Patel et al., 2016), and weak positive trends with telomere length were
reported albeit diﬀerent comparison methods hampered meta-analysis
to be conducted.
In addition to cross-sectional assessment of smoking status and
telomere length, three studies had two repeated measures of telomere
length. When adjusting for baseline telomere, telomere length mea-
sured 6 years later was inversely linked with number of cigarettes
smoked at baseline (Kingma et al., 2012), but not smoking status (Aviv
et al., 2009). Müezzinler and colleagues showed less telomere attrition
over 8 years among current compared to never smokers (Müezzinler
et al., 2015). Meta-analysis was not conducted due to the diﬀerent types
of measurements and interval time assessed.
Fig. 1. Selection of studies included in the systematic
review.
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Table 1
Description of studies included in the systematic review.
First author, year Country No. of participants Age Telomere length assessment Tissue source Overall association
Adams, 2007 UK 318 50 qPCR PBMC No association
Adler, 2013 USA 2599 70–79 qPCR leukocytes Shorter TL with smoking
Ahola, 2012 Finland 2911 30+ qPCR leukocytes No association
Aida, 2013 Japan 52 43–82 FISH oesophageal tissue No association
Ala-Mursula, 2013 Finland 5620 31 qPCR leukocytes No association
Atturu, 2010 UK 373 median 66 Southern blot leukocytes No association
Aulinas, 2015 Spain 154 mean 48.6 Southern blot leukocytes No association
Aviv, 2009 USA 635 24–44 Southern blot blood Shorter TL with smoking
Bakaysa, 2007 Sweden 175 mean 79 Southern blot blood No association
Balisteri, 2014 Italy 80 mean 63 Southern blot blood Shorter TL with smoking
Baragetti, 2015 Italy 768 mean 57 qPCR leukocytes Longer TL with smoking
Barcelo, 2010 Spain 404 46–52 qPCR leukocytes Shorter TL with smoking
Bekaert, 2007 Belgium 2509 35–55 Southern blot leukocytes No association
Bischoﬀ, 2006 Denmark 812 73–101 Southern blot leukocytes No association
Boccardi, 2013 Italy 217 mean 78 qPCR leukocytes No association
Boyer, 2015 France 201 53–66 qPCR blood No association
Brody, 2014 USA 216 22 qPCR PBMC* No association
Brouilette, 2003 UK 203 mean 47 Southern blot leukocytes No association
Brouilette, 2007 UK 1542 45–64 qPCR leukocytes No association
Carty, 2016 USA 1525 50–79 Southern blot leukocytes Shorter TL with smoking
Cassidy, 2010 USA 2284 30–55 qPCR leukocytes No association
Chen, 2014 USA 3256 45–74 qPCR blood No association
Chen, 2015 Chile 89 18+ qPCR saliva Shorter TL with smoking
Demissie, 2006 USA 327 40–89 Southern blot leukocytes No association
Diez Roux, 2009 USA 1000 45–84 qPCR blood No association
Ehrlenbach, 2009 Austria 669 mean 62 qPCR blood No association
Fitzpatrick, 2007 USA 419 65+ Southern blot leukocytes No association
Fyhrquist, 2011 Finland 1271 55–80 Southern blot leukocytes No association
Gu, 2015 USA 1743 mean 78 qPCR leukocytes No association
Haque, 2013 UK 126 18+ qPCR blood Shorter TL with smoking
Harris, 2006 UK 190 79+ qPCR leukocytes No association
Harris, 2012 UK 1048 mean 69 qPCR blood No association
Haver, 2015 Netherland 3275 60+ qPCR leukocytes Shorter TL with smoking
Hou, 2009 Poland 716 21–79 qPCR leukocytes Shorter TL with smoking
Houben, 2009 Netherland 122 mean 63 qPCR leukocytes No association
Immonen, 2012 Finland 198 mean 75 Southern blot blood No association
Kahl, 2015 Brazil 124 17–68 qPCR blood Shorter TL with smoking
Kingma, 2012 Netherland 895 28–75 qPCR leukocytes No association
Kozlitina, 2012 USA 3157 18–85 qPCR leukocytes No association
Latifovic, 2016 Canada 477 20–50 qPCR blood No association
Lee, 2012 USA 4324 35–60 qPCR leukocytes No association
Lee, 2015 Asian 1958 40–69 qPCR leukocytes Shorter TL with smoking
Li, 2011 Sweden 166 19–65 qPCR blood No association
Lin, 2013 China 231 50–64 qPCR oesophageal tissue No association
Liu, 2015 Canada 922 19+ qPCR leukocytes Shorter TL with smoking
Liu, 2011 China 360 mean 50 qPCR leukocytes No association
Lynch, 2013 Finland 853 50–69 qPCR blood Shorter TL with smoking
Marcon, 2012 Italy 56 mean 56 Southern blot blood No association
Mirabello, 2009 USA 1661 55–74 qPCR leukocytes Shorter TL with smoking
Morla, 2006 Spain 76 55–62 FISH leukocytes Shorter TL with smoking
Muezzinler, 2015 Germany 3597 50–75 qPCR leukocytes Shorter TL with smoking
Nawrot, 2010 Belgium 305 mean 42.5 Southern blot leukocytes Shorter TL with smoking
Needham, 2013 USA 5360 20–84 qPCR leukocytes Shorter TL with smoking
Neuner, 2016 Germany 343 18–70 qPCR blood No association
Nordfjall, 2008 Sweden 989 26–75 qPCR leukocytes No association
Parks, 2009 USA 647 35–74 qPCR blood Shorter TL with smoking
Pavanello, 2011 Italy 457 25–75 qPCR blood Shorter TL with smoking
Pellatt, 2012 USA 1268 30–79 qPCR blood Shorter TL with smoking
Rane, 2015 Singapore 90 45–74 Southern blot leukocytes No association
Raymond, 2013 South Africa 450 case 51, control 40 qPCR leukocytes No association
Revesz, 2013 Netherland 2936 18–65 qPCR leukocytes Shorter TL with smoking
Risques, 2007 USA 300 30–89 qPCR leukocytes No association
Rode, 2014 Denmark 55,568 20–100 qPCR leukocytes Shorter TL with smoking
Sabatino, 2013 Italy 11 mean 67 qPCR blood Shorter TL with smoking
Sadr, 2015 Iran 189 mean 65 qPCR blood No association
Sanchez-Espiridion, 2014 USA 2790 mean 62 qPCR lymphocytes Shorter TL with smoking
Satoh, 1996 Japan 166 62–95 Southern blot leukocytes No association
Savale, 2009 France 291 55–70 qPCR blood No association
Song, 2010 USA 103 18–80 qPCR T-lymphocytes Shorter TL with smoking
Steptoe, 2011 UK 506 53–76 qPCR PBMC* No association
Strandberg, 2011 Finland 622 30–45 Southern blot blood Shorter TL with smoking
Surtees, 2012 UK 4441 41–80 qPCR leukocytes Shorter TL with smoking
Tsuji, 2006 Japan 34 mean 63 FISH lung tissue Shorter TL with smoking
Tyrka, 2015 USA 392 18–64 qPCR blood No association
(continued on next page)
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3.2. Assessment of quality of included studies
To assess the risk of bias, we used criteria adapted from the CASP
questionnaires for observational studies. As shown in Table S2
(Supplementary Information),all studies demonstrated clear aims, and
adjustment for important confounding variables was applied in 42 out
of 84 studies. Accurate measurements of exposure and outcome was
indicated in the majority of studies, with seventy-six studies clearly
described their methods in assessing LTL, and seventy one studies de-
scribed how smoking was measured.
3.3. Assessment of publication bias
Assessment of publication bias was conducted for the studies in-
cluded in the meta-analysis which compared telomere length between
smokers and non-smokers (Fig. 2A) as well as ever and never smokers
(Fig. 2B), which each contained more than 10 studies. Both visual in-
spection and formal test for funnel plot asymmetry indicated symme-
trical distribution (Egger's test p-values = 0.12 in analysis comparing
smokers and non-smokers and 0.41 when comparing ever and never
smokers), indicating that small study eﬀects, which may reﬂect
publication bias, were unlikely.
3.4. Meta-analysis of association between smoking and telomere length
Meta-analyses were performed for 30 studies which provided com-
parable estimates for association between self-reported smoking ex-
posures and telomere length. As several studies reported individual
analyses either between smokers (current smokers) and non-smokers
(former and never smokers) or ever (current and former smokers)
smokers and never smokers, meta-analyses were carried out separately
for each comparison. We found that telomere length were lower among
smokers compared to non-smokers, with a pooled SMD of−0.17 (95%
CI−0.24 to−0.09) (Fig. 3A). Moderate heterogeneity was found (I2 =
60.47%). Similarly, telomere length was lower among ever smokers
than never smokers (Fig. 3B), with a summary SMD of −0.11 (95% CI
−0.16 to−0.07), with I2 indicating a lack of substantial heterogeneity
(I2 = 46.51%). A sensitivity analysis excluding one study at a time one
at a time was performed in analysis comparing smokers and non-smo-
kers. This analysis showed reduced heterogeneity (I2 = 26.87%) when
a study by Wang and colleagues was removed, with summary SMD of
−0.13 (95% CI −0.17 to −0.07) (Fig. S1).
We further evaluated diﬀerence in telomere length across current,
former and never smokers. Telomere length was suggested to be lower
among current compared to never smokers (summary SMD: −0.15,
95% CI: −0.28 to −0.02) and or compared to former smokers (sum-
mary SMD: −0.06, 95% CI: −0.13 to 0). No diﬀerence in mean telo-
mere length was observed between former and never smokers (Fig. 4).
There was moderate heterogeneity when comparing current to never
smokers and high heterogeneity (I2> 75%) when comparing former to
never smokers. In the sensitivity analyses excluding one study at a time,
we found that exclusion of a study by Needham et al. lowered the
heterogeneity substantially with I2 less than 20% in comparison of
telomere length between current and never smokers (Fig. S2, summary
SMD: −0.20, 95% CI −0.30 to −0.10). Similar reduction in hetero-
geneity was shown by excluding a study by Muezzinler et al. when
comparing former and never smokers (Fig. S3), with summary results
indicating no diﬀerence in telomere length between the two groups
(summary SMD: −0.01, 95% CI −0.09 to 0.07).
Five studies provided comparable estimates for mean diﬀerence of
telomere length by categories of pack-years of smoking (Table S3,
Supplementary Information), and they were included in a dose-re-
sponse meta-analysis assessing the association between pack-year of
smoking and telomere length. As shown in Fig. 5, assuming a linear
relationship, there was an inverse trend between pack-years of smoking
and telomere length. Each increase in pack-years of smoking corre-
sponded to−0.01 decrease in mean telomere length (95% CI:−0.03 to
−0.002) and high heterogeneity was indicated (I2 = 98.2%). Use of a
quadratic model did not show any improvement of the model ﬁt. In the
sensitivity analysis, excluding any of the studies in the sensitivity
analysis did not remove the observed heterogeneity.
Table 1 (continued)
First author, year Country No. of participants Age Telomere length assessment Tissue source Overall association
Valdes, 2005 UK 561 mean 48.6 qPCR leukocytes Shorter TL with smoking
Verde, 2015 Spain 147 25–65 qPCR leukocytes No association
Von Kanel, 2015 South Africa 341 25–65 qPCR leukocytes No association
Wang, 2011 China 275 40–73 qPCR leukocytes No association
Wang, 2014 China 934 mean 43 qPCR lymphocytes Shorter TL with smoking
Whisman, 2016 USA 684 mean 53 qPCR saliva No association
Wong, 2014 USA 87 18+ qPCR leukocytes No association
Woo, 2009 China 4000 65+ qPCR leukocytes Shorter TL with smoking
Xiao, 2011 China 1797 mean 64 qPCR leukocytes Shorter TL with smoking
Zee, 2010 USA 518 40–84 qPCR leukocytes No association
Note: TL = telomere length; BMC = peripheral blood mononuclear cells; qPCR = quantitative polymerase chain reaction.
Fig. 2. Funnel plots for associations between (A) smokers or non-smokers or (B) ever and
never smokers and telomere length. X-axes represent standardized mean diﬀerence of
telomere length and Y-axis represent their standard error.
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4. Discussion
To our knowledge, this is the ﬁrst systematic review and meta-
analysis on cigarette smoking and telomere length. We found that tel-
omere length was shorter among ever smokers compared to those never
smoked. Among those who ever smoked, telomere length was indicated
to be shorter among current smokers compared to those who quitted
smoking. Using a dose-response meta-analysis, we found a weak inverse
association between pack-years of smoking and telomere length. When
assessing risk of bias, we found that half of included studies have ad-
justed for confounding variables in their analysis. Substantial hetero-
geneity was shown in some of the ﬁndings.
The observed associations may suggest that biological ageing, in-
dicated by telomere length, is enhanced with active smoking. A plau-
sible mechanism is that free radicals generated following cigarette
smoking may induce oxidative stress and inﬂammation (Thorne et al.,
2009), resulting in signiﬁcantly shortened telomeres and lead to
cellular senescence and apoptosis (d’Adda di Fagagna et al., 2003; Von
Zglinicki, 2002). Our results also indicated the beneﬁt of quitting
smoking compared to being current smokers with regards to telomere
length. There was a weak indication that former smokers who quitted
smoking for a longer period of time may have longer telomeres com-
pared to those who quit more recently or current smokers (Müezzinler
et al., 2015; Wulaningsih et al., 2016), although a meta-analysis was
not feasible. Additionally, higher pack-years of smoking, which reﬂect
lifelong cigarette smoking exposure, corresponded to shorter telomeres
although heterogeneity was shown. Altogether, these ﬁndings indicate
the need to investigate whether there are cumulative eﬀects of smoking
on telomere length, and correspondingly, any reversal of such eﬀects
with longer period of smoking cessation. Studying the dynamic of tel-
omere shortening may add understanding into such impact of smoking
and cessation since it better reﬂects the biological impact of environ-
mental inﬂuences compared to a single measurement of telomere length
(Chen et al., 2011; Nordfjäll et al., 2009; Svenson et al., 2011). In the
Fig. 3. Comparison of means of telomere length between (A) smokers and non-smokers and (B) between ever or never smokers.
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study by Müezzinler and colleagues in which repeated measures of
telomere length 8-year apart were assessed, greater telomere loss was
shown with longer period of quitting smoking among ever smokers,
albeit non-signiﬁcant (Müezzinler et al., 2015). The same study also
showed that those who were current smokers at baseline had sub-
sequent less telomere attrition than never smokers. Such conﬂicting
ﬁnding may be explained by the “thrifty telomere” hypothesis
(Eisenberg, 2011), which suggests that telomere length may act as a
marker of one's limited resources over the life course or “disposable
soma” (Kirkwood and Holliday, 1979). This theory states that having
shorter telomeres to start with results in a more thrifty investment in
maintenance eﬀorts and reduced cell proliferation (Eisenberg, 2011),
which may explain greater telomere length but more pronounced sub-
sequent telomere loss with longer time of smoking cessation
(Müezzinler et al., 2015). Further investigations regarding the role of
smoking and its cessation on telomere length and attrition is therefore
necessary to conﬁrm such complex association.
The strength of this review lies in the use of diﬀerent measures of
smoking exposures ranging from self-report to objective biomarker
measurements, and the inclusion of studies which included smoking as
covariates when appropriate in addition to those evaluating smoking as
the main exposure. We were able to estimate the dose-response re-
lationship between smoking intensity, calculated as pack-years of
smoking, with telomere length. Nevertheless, there was high hetero-
geneity when comparing telomere length between current and former
smokers. Diﬀerences in population demographics may have explained
such heterogeneity since exclusion of one Asian study (Wang et al.,
2011) removed the heterogeneity observed when comparing ever and
never smokers. However, less heterogeneity for other analyses were
observed when excluding population-based studies which mostly in-
cluded Caucasians (Müezzinler et al., 2015; Needham et al., 2013),
which may indicate that there might have been factors other than
Fig. 4. Comparison of means of telomere length between (A) current and former smokers, (B) between current and never smokers and (C) between former and never smokers.
Fig. 5. Dose-response association between pack-years of smoking and telomere length.
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ethnicities which explained the observed heterogeneity. It is unlikely
that study design or telomere tissue explained this heterogeneity as all
included studies in the analysis measured smoking status and telomere
length cross-sectionally and used peripheral blood cells. Another pos-
sible source of heterogeneity might be the inter-laboratory technical
variation of quantitative PCR (qPCR) to measure relative telomere
length, which tend to yield higher variability than Southern blotting
(Aviv et al., 2011; Gardner et al., 2014), although a study by Martin-
Ruiz et al. suggested that both techniques show comparable intra- and
inter-assay inconsistencies (Martin-Ruiz et al., 2015). Previous meta-
analyses on cross-sectional associations between other lifestyle-related
factors such as hypertension or obesity and leukocyte telomere length
also reported high heterogeneity (Mundstock et al., 2015; Tellechea and
Pirola, 2016), which may indicate the need to address methodological
problem in telomere association study that should involve standardi-
sation of qPCR and Southern blotting protocols (Martin-Ruiz et al.,
2015).
Another limitation was that most included studies only used a single
assessment of telomere length, which indicates the need to extend such
analysis with repeated measurements. Furthermore, all studies included
in the meta-analysis assessed circulating telomere length in blood. We
were unable to assess any potential eﬀect modiﬁcation by sample
source of telomere length such as saliva, which has also been linked to
smoking (Zhang et al., 2016). Leukocyte telomere length has been
widely used as a representative parameter of individual telomere status
and that shorter leukocyte telomere length has been linked with in-
creased mortality in several studies (Kimura et al., 2008; Needham
et al., 2015). Nevertheless, the evidence regarding correlation of telo-
mere length in leukocytes and other tissues is conﬂicting (Daniali et al.,
2013; Dlouha et al., 2014; Friedrich et al., 2000; Gadalla et al., 2010;
Lakowa et al., 2015; Mather et al., 2011). There are discrepancies in
both telomere length and attrition rate of granulocytes and lympho-
cytes subpopulation (Mather et al., 2011; Sanders and Newman, 2013).
Additionally, a study by Svenson et al. demonstrated ﬂuctuation in
leukocyte telomere length during the course of 6 months (Svenson
et al., 2011). This ﬂuctuation may be due to natural cycle or environ-
ment factors, such as acute infection, that changes the composition of
leukocyte subpopulations and their replicative state (Akbar and
Vukmanovic-Stejic, 2007; Hodes et al., 2002). Leukocyte is therefore
not necessarily an ideal surrogate marker for other tissues in cross-
sectional or short longitudinal studies. Most of our studies were of
cross-sectional nature, therefore, our results only suggest association
instead of causation. Having certain diseases, such as chronic ob-
structive lung disease, may result in smoking cessation and thus con-
found association between smoking status and telomere length. Esti-
mates collected from included studies were adjusted for age, when
information was available, in order to take into account the eﬀect of
age-related disease. However, residual confounding may still have oc-
curred. We were able to capture lifelong exposure of smoking by pack-
years of smoking, but this was based on self-report and therefore prone
to recall bias. However, this was likely to result in non-diﬀerential
misclassiﬁcation because our outcome was a biomarker rather than any
existing disease. Although we were unable to do a meta-analysis for
cotinine levels, high agreement (~90%) has been shown between self-
report active smoking status and cotinine levels (Arheart et al., 2008).
To further tease out this association, a life course approach which al-
lows assessment of smoking exposure prior to telomere length assess-
ment, and use of repeated telomere measures may enhance under-
standing into the mechanisms of which smoking may inﬂuence
telomere length.
5. Conclusion
In summary, this review showed that telomere length was shorter
among ever smokers compared to those who never smoked, and among
current smokers compared to former smokers. As shorter telomere may
be a marker of early changes in ageing-related disease, the beneﬁt
suggested among former smokers compared to current smokers may
further indicate the need to optimise policies targeting smoking cessa-
tion, particularly at earlier age. However, heterogeneity found in some
of our ﬁndings indicates the need for further studies to quantify the
implication of speciﬁc smoking exposures on telomere length and bio-
logical ageing.
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